Colgate-Palmolive (NYSE:CL) Position Lowered by Duncker Streett & Co. Inc.

Duncker Streett & Co. Inc. decreased its stake in shares of Colgate-Palmolive (NYSE:CL) by 1.3% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 14,723 shares of the company’s stock after selling 192 shares during the period. Duncker Streett & Co. Inc.’s holdings in Colgate-Palmolive were worth $1,174,000 as of its most recent filing with the SEC.

Several other large investors have also modified their holdings of CL. Dimensional Fund Advisors LP lifted its position in shares of Colgate-Palmolive by 4.0% during the first quarter. Dimensional Fund Advisors LP now owns 2,444,508 shares of the company’s stock worth $185,376,000 after purchasing an additional 94,837 shares during the last quarter. Covestor Ltd lifted its position in shares of Colgate-Palmolive by 71.9% during the first quarter. Covestor Ltd now owns 2,451 shares of the company’s stock worth $186,000 after purchasing an additional 1,025 shares during the last quarter. Mackenzie Financial Corp raised its stake in Colgate-Palmolive by 8.5% during the first quarter. Mackenzie Financial Corp now owns 1,882,813 shares of the company’s stock worth $142,774,000 after acquiring an additional 146,936 shares during the period. First Western Trust Bank acquired a new stake in Colgate-Palmolive during the first quarter worth about $569,000. Finally, Wsfs Capital Management LLC acquired a new stake in Colgate-Palmolive during the first quarter worth about $288,000. Institutional investors own 80.41% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts recently weighed in on CL shares. Wells Fargo & Company increased their price objective on shares of Colgate-Palmolive from $80.00 to $88.00 and gave the stock an “equal weight” rating in a research note on Monday, January 29th. JPMorgan Chase & Co. increased their price objective on shares of Colgate-Palmolive from $88.00 to $90.00 and gave the stock an “overweight” rating in a research note on Thursday, January 18th. Barclays increased their price objective on shares of Colgate-Palmolive from $82.00 to $84.00 and gave the stock an “equal weight” rating in a research note on Friday, April 12th. Raymond James upgraded shares of Colgate-Palmolive from a “market perform” rating to an “outperform” rating and set a $91.00 price objective on the stock in a research note on Monday, January 29th. Finally, Stifel Nicolaus raised their price target on shares of Colgate-Palmolive from $89.00 to $94.00 and gave the company a “buy” rating in a research note on Wednesday, April 10th. Three research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $89.50.

Insider Activity

In other news, insider Jennifer Daniels sold 3,538 shares of the firm’s stock in a transaction on Tuesday, February 20th. The shares were sold at an average price of $84.67, for a total transaction of $299,562.46. Following the transaction, the insider now owns 59,698 shares in the company, valued at approximately $5,054,629.66. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, insider Jennifer Daniels sold 3,538 shares of Colgate-Palmolive stock in a transaction on Tuesday, February 20th. The shares were sold at an average price of $84.67, for a total value of $299,562.46. Following the transaction, the insider now owns 59,698 shares in the company, valued at approximately $5,054,629.66. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Noel R. Wallace sold 69,948 shares of Colgate-Palmolive stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $84.22, for a total transaction of $5,891,020.56. Following the completion of the transaction, the chief executive officer now owns 286,881 shares in the company, valued at approximately $24,161,117.82. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 232,371 shares of company stock worth $19,505,099. 0.37% of the stock is owned by corporate insiders.

Colgate-Palmolive Price Performance

Shares of Colgate-Palmolive stock remained flat at $86.17 on Wednesday. 3,220,548 shares of the stock traded hands, compared to its average volume of 3,530,158. The business has a 50 day simple moving average of $86.92 and a 200-day simple moving average of $80.58. The company has a current ratio of 1.11, a quick ratio of 0.71 and a debt-to-equity ratio of 8.59. The stock has a market cap of $70.83 billion, a P/E ratio of 30.99, a PEG ratio of 3.28 and a beta of 0.42. Colgate-Palmolive has a twelve month low of $67.62 and a twelve month high of $90.37.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, January 26th. The company reported $0.87 earnings per share for the quarter, topping analysts’ consensus estimates of $0.85 by $0.02. The firm had revenue of $4.95 billion during the quarter, compared to analysts’ expectations of $4.89 billion. Colgate-Palmolive had a net margin of 11.82% and a return on equity of 509.75%. The firm’s revenue for the quarter was up 6.9% compared to the same quarter last year. During the same period last year, the firm posted $0.77 earnings per share. On average, equities research analysts predict that Colgate-Palmolive will post 3.49 earnings per share for the current fiscal year.

Colgate-Palmolive Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Monday, April 22nd will be issued a dividend of $0.50 per share. The ex-dividend date of this dividend is Friday, April 19th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.32%. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.48. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 69.06%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.